GlassScriptPhysician profile
Patricia A Frey
NPI 1558420562
$2,604.28
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $445 · 2021: $496 · 2022: $384 · 2023: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $539 · Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $539.21 |
| Food and Beverage | $330.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $662.01 | 2023 | Ligasure |
| Abbvie INC. | $643.57 | 2019-2023 | |
| Galderma Laboratories, L.P. | $208.68 | 2019 | |
| Mayne Pharma Commercial LLC | $121.28 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $113.05 | 2019-2022 | |
| Exeltis, USA INC. | $107.08 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.29 | 2020-2021 | |
| Allergan, INC. | $81.12 | 2019-2022 | |
| Hologic Sales and Service, LLC | $77.11 | 2021-2023 | Myosure Tissue Removal Device |
| Therapeuticsmd, INC. | $75.19 | 2019-2021 | |
| Myovant Sciences INC. | $72.58 | 2021-2022 | |
| Lupin INC. | $45.57 | 2020 | |
| Amag Pharmaceuticals, INC. | $29.96 | 2019-2020 | |
| Ethicon US, LLC | $27.94 | 2021 | |
| Mission Pharmacal Company | $25.94 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $23.29 | 2023 | Twirla |
| Organon LLC | $22.42 | 2022 | |
| Astellas Pharma US INC | $21.53 | 2023 | Veozah |
| Mycovia Pharmaceuticals, INC. | $20.42 | 2023 | Vivjoa |
| Exact Sciences Corporation | $17.20 | 2023 | Cologuard Collection Kit |
| Alk-Abello, INC | $17.12 | 2020 | |
| Mylan Pharmaceuticals INC. | $17.07 | 2022 | |
| Kerecis Limited | $16.96 | 2021 | |
| Shield Therapeutics INC | $16.89 | 2022 | |
| Minerva Surgical, INC | $16.84 | 2019 | |
| Amgen INC. | $11.67 | 2022 | |
| Avion Pharmaceuticals | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.